An Overview of Pharmaceutical Excipients: Safe or Not Safe?

被引:84
作者
Abrantes, Catia G. [1 ]
Duarte, Dinah [1 ]
Reis, Catarina P. [1 ,2 ,3 ]
机构
[1] Univ Lusofona Humanidades & Tecnol, Sch Sci & Hlth Technol, Lisbon, Portugal
[2] Univ Lusofona Humanidades & Tecnol, CBIOS Res Ctr Biosci & Hlth Technol, Lisbon, Portugal
[3] Univ Lisbon, Fac Sci, Biophys & Biomed Engn, IBEB, Lisbon, Portugal
关键词
excipients; toxicology; drug interactions; pre-formulation; stability; solid dosage form; DIFFERENTIAL SCANNING CALORIMETRY; IN-VITRO CHARACTERIZATION; OXIDATIVE-DEGRADATION; MAILLARD REACTION; DELIVERY-SYSTEM; DRUG; COMPATIBILITY; HYDROCHLORIDE; FORMULATION; CYCLODEXTRINS;
D O I
10.1016/j.xphs.2016.03.019
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A medicine consists of 2 fundamental parts: the active pharmaceutical ingredient and the excipient. Most, if not all, medicines could not be made without the use of excipients. In the early times, the safety of excipients was overlooked and no specific safety tests were generally conducted. This fact has been changed over times and is currently being recognized that the excipient's toxicity is not negligible, because its direct interaction with the active pharmaceutical ingredient or between other excipients may occur, leading to a potential change in the relationship between effectiveness and toxicity. This review is intended to address the general status of the pharmaceutical excipients and to describe the safety assessment. As a summary, this review suggests the interest of simplifying the formulations as much as possible and the interest of reducing the number of excipients necessary to strictly meet the required functions. The risk/benefit ratio of an excipient should be always evaluated on the basis of not only its production and quality but also of its safety. Further research according to Good Manufacturing Practices, Guiding Principles in Toxicology Assessment, Good Laboratory Practices, and Good Distribution Practices requirements are needed and are fundamental for health safety, contributing to a comprehensive picture of this matter. (C) 2016 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:2019 / 2026
页数:8
相关论文
共 122 条
  • [91] Rowe RC., 2009, Handbook of Pharmaceutical Excipients, VSixth edit, P917
  • [92] Sabnis S, 1997, Pharm Dev Technol, V2, P243, DOI 10.3109/10837459709031444
  • [93] Satish, 2004, PHARM TECHNOL, P52
  • [94] Saunders W., 1974, DORLANDS MED DICT
  • [95] Comparative study of the effect of pharmaceutical additives on the elimination of antibiotic activity during the treatment of oxacillin in water by the photo-Fenton, TiO2-photocatalysis and electrochemical processes
    Serna-Galvis, Efraim A.
    Silva-Agredo, Javier
    Giraldo, Ana L.
    Florez-Acosta, Oscar A.
    Torres-Palma, Ricardo A.
    [J]. SCIENCE OF THE TOTAL ENVIRONMENT, 2016, 541 : 1431 - 1438
  • [96] Silverstein I., 2005, PHARM TECH, P1
  • [97] A new approach to accelerated drug-excipient compatibility testing
    Sims, JL
    Carreira, JA
    Carrier, DJ
    Crabtree, SR
    Easton, L
    Hancock, SA
    Simcox, CE
    [J]. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2003, 8 (02) : 119 - 126
  • [98] International conference on harmonization of technical requirements for registration of pharmaceuticals for human use
    Singh, Jatinder
    [J]. JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2015, 6 (03) : 185 - 187
  • [99] SINGH P, 1966, J PHARM SCI-US, V55, P63
  • [100] Adsorption of an amine drug onto microcrystalline cellulose and silicified microcrystalline cellulose samples
    Steele, DF
    Edge, S
    Tobyn, MJ
    Moreton, RC
    Staniforth, JN
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2003, 29 (04) : 475 - 487